2 Million Asthma Patients to Be Disenrolled From Medicaid

Why It Matters

The policy could trigger widespread loss of health coverage for a vulnerable population, leading to increased asthma hospitalizations and higher overall health‑care costs. It also raises legal and policy challenges around equitable access to care for patients with chronic respiratory disease.

Key Takeaways

• Over 2 million Medicaid asthma patients risk disenrollment under work requirements
• 61% work fewer than 20 hours weekly, failing the 80‑hour rule
• One‑third have poor physical health; another third suffer poor mental health
• High rates of daily controller use and recent exacerbations signal severe disease
• State exemptions vary, leaving many medically frail patients without clear protection

Pulse Analysis

The federal push to attach work requirements to Medicaid has resurfaced with the passage of the so‑called Big Beautiful Bill, a bipartisan effort that mandates adult beneficiaries to log at least 80 hours of employment each month to retain coverage. Proponents argue the rule will incentivize labor force participation and reduce program spending, but critics warn it ignores the socioeconomic realities of low‑income households. Set to roll out in January 2027, the legislation will affect roughly 20 million Medicaid enrollees nationwide, making the projected disenrollment of over two million asthma patients a flashpoint for health‑policy debates.

A recent analysis presented at the American Thoracic Society conference examined 2022‑2023 data from the Medical Expenditure Panel Survey and found that 61 % of Medicaid‑insured adults with asthma work fewer than 20 hours per week, far short of the 80‑hour benchmark. Moreover, nearly half of this cohort reported an asthma exacerbation in the past year, and more than a third exhibited poor physical or mental health scores. Interruptions in coverage could halt access to controller inhalers, routine check‑ups, and timely emergency care, driving up hospital admissions and overall health‑care expenditures.

The study underscores the urgency for policymakers and clinicians to shape exemption criteria that reflect real‑world functional limitations rather than a binary work/no‑work metric. Since states will interpret medical frailty standards independently, disparities in protection are likely to emerge, leaving many patients in a “gray zone” without clear recourse. Advocacy from pulmonology societies, patient groups, and health‑economics researchers can help ensure that any work‑requirement framework incorporates comprehensive disability assessments, thereby safeguarding vulnerable asthma patients while addressing fiscal concerns.